"Radiotherapy, Adjuvant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
| Descriptor ID |
D018714
|
| MeSH Number(s) |
E02.186.775 E02.815.600
|
| Concept/Terms |
Radiotherapy, Adjuvant- Radiotherapy, Adjuvant
- Adjuvant Radiotherapy
- Adjuvant Radiotherapies
- Radiotherapies, Adjuvant
|
Below are MeSH descriptors whose meaning is more general than "Radiotherapy, Adjuvant".
Below are MeSH descriptors whose meaning is more specific than "Radiotherapy, Adjuvant".
This graph shows the total number of publications written about "Radiotherapy, Adjuvant" by people in this website by year, and whether "Radiotherapy, Adjuvant" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 2 | 3 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 4 | 4 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 4 | 4 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 6 | 6 |
| 2009 | 0 | 3 | 3 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 8 | 8 |
| 2012 | 0 | 3 | 3 |
| 2013 | 0 | 8 | 8 |
| 2014 | 1 | 2 | 3 |
| 2015 | 1 | 7 | 8 |
| 2016 | 1 | 2 | 3 |
| 2017 | 1 | 5 | 6 |
| 2018 | 1 | 5 | 6 |
| 2019 | 0 | 5 | 5 |
| 2020 | 0 | 6 | 6 |
| 2021 | 0 | 4 | 4 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Radiotherapy, Adjuvant" by people in Profiles.
-
Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine. J Clin Endocrinol Metab. 2025 Jan 21; 110(2):e208-e217.
-
The Landmark Series: Neoadjuvant Radiotherapy in Extremity Soft Tissue Sarcoma-The Way to Hypofractionation. Ann Surg Oncol. 2025 Mar; 32(3):1489-1496.
-
Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery. J Natl Cancer Inst. 2025 Jan 01; 117(1):103-111.
-
Neoadjuvant Radiotherapy and Endocrine Therapy for Oestrogen Receptor Positive Breast Cancers: The Neo-RT Feasibility Study. Clin Oncol (R Coll Radiol). 2025 Jan; 37:103669.
-
Does pre-irradiation gross tumor volume predict the risk of progression after radiation therapy in pediatric patients with adamantinomatous craniopharyngioma? J Neurosurg Pediatr. 2024 Dec 01; 34(6):642-648.
-
Financial Improvements From Short Course Adjuvant Vaginal Cuff Brachytherapy in Early Endometrial Cancer Compared With Standard of Care, "SAVE" Trial. Pract Radiat Oncol. 2024 Nov-Dec; 14(6):e500-e506.
-
Hypofractionated Preoperative Radiation Should Not Yet Be Used as Standard of Care for Extremity and Truncal Soft Tissue Sarcoma. J Clin Oncol. 2024 Dec 20; 42(36):4240-4245.
-
Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy. Eur J Surg Oncol. 2024 Dec; 50(12):108613.
-
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT? PREDICT Study. Ann Surg Oncol. 2024 Sep; 31(9):5919-5928.
-
ASO Author Reflections: The Role of Postoperative Radiation Therapy Following Wide Excision of Neurotropic Melanoma of the Head and Neck: Now and into the Future. Ann Surg Oncol. 2024 Sep; 31(9):6118-6119.